|
|
|
Researchers at the University of Miami School of Medicine compared the outcomes of cirrhotic patients who underwent liver transplants for nonalcoholic steatohepatitis (NASH) versus alcoholic liver disease (ETOH) and found no...
Adding a biological agent to standard chemotherapy in difficult-to-treat cases of colorectal liver metastases significantly improved responses, researchers said. In a randomized, Phase II study of patients whose tumors were...
Drug plus chemo boosts surgery success for patients with liver lesions, researchers find WEDNESDAY, Nov. 25 (HealthDay News) -- Adding the drug cetuximab to neoadjuvant chemotherapy can shrink tumors and boost the odds of...
From antioxidant-rich foods to hormone therapies to all-natural cleanses, there are countless cancer-fighting promises on the market today. Don't smoke: The risk of smoking-related cancers increases with the length of time a...
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, recently sponsored a Satellite Symposium at the World Meeting of Melanoma/Skin Cancer...
GREENWICH, CT -- (Marketwire) -- 11/24/09 -- On October 5th, 2009, the Stone Point Capital Foundation hosted its fifth Charity Golf Tournament and Dinner at The Stanwich Club of Greenwich, to benefit The Fibrolamellar Cancer...
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall survival data from the first 20 subjects in the current Phase...
Centers of Excellence program recognizes the top performing treating hospitals that provide SIR-Spheres® microspheres therapy to patients with inoperable liver tumors Sirtex Medical Inc., a leading developer of targeted and...
Australian National University Medical School at The Canberra Hospital, ACT, Australia. BACKGROUND:: p53 mutations are very common in human hepatocellular carcinoma, and induction of hepatic p53 expression causes lysis of...
Researchers detail in 'Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas,' new data in hepatocellular cancer. "This study evaluated the efficacy of repeat hepatic resection for recurrent...
